Investegate | Company Announcement

Investegate announcements from PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

Related Keywords

France ,Cambridge ,Cambridgeshire ,United Kingdom ,Paris ,France General ,United States ,New York ,French ,American ,Eric Soyer ,Pherecydes Pharma ,Pharma Bio ,Enregistrement Universel ,Arthur Rouill ,Company Securities ,Company Adss ,Exchange Commission ,Nasdaq Stock Market Of The Company ,Securities Exchange ,Adss For The Company ,Euronext ,Company Annual Report On Form ,Nasdaq ,Receipt Administration ,American Depositary Shares ,Nasdaq Capital ,Euronext Paris ,Nasdaq Stock Market ,Nasdaq Global Select Market ,Nasdaq Capital Market ,Chief Financial Officer ,Securities Exchange Act ,New York Mellon ,Restated Deposit Agreement ,Deposit Agreement ,American Depositary Receipts ,Depositary Receipt ,For Settlement ,Next Biotech ,French Autorit ,Des March ,Registration Document ,Annual Report ,